Levofloxacin intermediates are key pharmaceutical building blocks used in the multistep synthesis of the broad-spectrum fluoroquinolone antibiotic Levofloxacin API. These intermediates typically include chiral heterocyclic precursors and functionalized fluorinated molecular scaffolds that serve as crucial structural cores before being transformed into the final active pharmaceutical ingredient. High‑quality intermediates ensure efficient downstream reactions, enable controlled stereochemistry, and support consistent API yield and purity. They are widely supplied to drug manufacturers and custom synthesis providers for industrial API production and regulatory filings. Intermediates specifically tailored for Levofloxacin synthesis often involve substituted pyrido‑benzoxazine or pyridone intermediates that determine the antibiotic’s pharmacophore arrangement and facilitate subsequent coupling with amines such as N‑methylpiperazine. Their dependable supply and consistent quality are essential for scalable and compliant antibiotic manufacturing.
Levofloxacin Intermediates Characteristics
Chiral integrity assurance: Maintains optical purity, reducing the need for extensive chiral purification.
Optimized synthetic profiles: High reaction conversion and predictable process performance across multi-step synthesis.
Process reproducibility: Strict quality controls ensure consistent batch-to-batch performance, crucial for pharmaceutical compliance.
| Name | CAS Number | Molecular Formula | Molecular Weight（g/mol） | Chemical Structure |
| Ethyl 3‑oxo‑3‑(2,3,4,5‑tetrafluorophenyl)propanoate | 94695‑50‑8 | C11H8F4O3 | 264.17 |  |
| Levofloxacin N‑oxide | 117678‑38‑3 | C18H20FN3O5 | 377.3669032 |  |
| 9‑Desfluoro levofloxacin | 117620‑85‑6 | C18H21N3O4 | 343.38 |  |
Levofloxacin intermediates serve as essential precursors in the synthesis of Levofloxacin, a broad-spectrum fluoroquinolone antibiotic. These intermediates contain key chiral and heterocyclic structures that are crucial for forming the active pharmacophore of the final drug. By preserving stereochemistry and functional groups, they enable the formation of the quinolone core that interacts with bacterial DNA gyrase and topoisomerase IV. High-quality intermediates ensure that downstream chemical transformations proceed efficiently, producing the active Levofloxacin molecule with consistent purity, yield, and biological activity, ultimately determining the drug’s antibacterial potency and spectrum.
Levofloxacin
A broad-spectrum fluoroquinolone antibiotic used for respiratory, urinary tract, and skin infections; intermediates enable formation of the quinolone core targeting bacterial DNA replication.
Ofloxacin
Intermediates contribute to the synthesis of Ofloxacin, treating bacterial prostatitis and sinusitis by inhibiting DNA gyrase and topoisomerase IV.
Ciprofloxacin derivatives
Serve as precursors for modified fluoroquinolone drugs, acting against Gram-negative and Gram-positive bacteria through disruption of bacterial DNA synthesis.
B608, #25 Shenbin Rd, Minhang District, Shanghai, China
English
